Home / Lifestyle / Health & Fitness / Article / New gene drug combined with hormone therapy improves breast cancer patients's survival rate: Study

New gene drug combined with hormone therapy improves breast cancer patients's survival rate: Study

The results, published in the Lancet Oncology journal, showed the breast cancer patients who were given Capivasertib, developed by AstraZeneca, survived almost twice as long than those given the standard treatment alone

  • WhatsAppBookmarkBookmark
Listen to this article :
Image for representational purpose only. Photo: istock

Image for representational purpose only. Photo: istock

Women with a genetic abnormality in their cancer given a new gene drug, combined with hormone therapy, improved their survival rate, according to trial results.

The results, published in the Lancet Oncology journal, showed the breast cancer patients who were given Capivasertib, developed by AstraZeneca, survived almost twice as long than those given the standard treatment alone, BBC reported.

Read Next Story
Know your diet right: Here are some of the nutrition myths Indians believe in›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All